GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA
Delisted
GRNA was delisted on the 21st of July, 2023.
50 hedge funds and large institutions have $65.2M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
77% less capital invested
Capital invested by funds: $280M → $65.2M (-$215M)
Holders
50
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.47M | |
| 2 | +$547K | |
| 3 | +$424K | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
+$256K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$246K |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$3.85M | |
| 3 | -$1.21M | |
| 4 |
Jane Street
New York
|
-$686K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$604K |